We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
Dr. Francesco Piraino, Scientist Bioengineer - Quanterix, Inc,
"Monitoring Health and Disease Progression with Utrasensitive Biomarker Analysis"
Quanterix Simoa™ technology detects proteins with 1000]fold higher sensitivity than traditional immunoassays
ltrasensitive detection is enabling the identification of more informative biomarkers requiring less invasive and less expensive testing proceduresto improve our understanding of neurodegenerative disease.Simoa assays are currently applied across various therapeutic areas including neurology, oncology, cardiology, inflammation and infectiousdisease to detect biomarkers in a variety of sample matrices.Quanterix cytokine assays lead the field with respect to precision, disease correlation and detection of endogenous analytes.Quanterix offers a large menu of commercially available assays, an open instrument platform for developing homebrew assays, and assay testing services.
BIO: Francesco Piraino is a research scientist at the Swiss Federal Institute of Technology in Lausanne (Switzerland). He uses microscale technologies to develop next-generation microfluidic diagnostics platforms. Following his graduate studies in Biomedical Engineering at Politecnico di Milano (Italy) and at Harvard-MIT Division of Health Science & Technology (USA), he joined the Broad Institute of MIT and Harvard (USA) to develop devices for single-cell genomics. Dr. Piraino is a trained bioengineer who has also attended programs at the Universitat de Barcelona (Spain), the CityCollege of the City University of New York (USA), and the Massachusetts Institute of Technology (USA). His work aims to solve problems at the intersection of biomedical engineering and medicine.
Host: Clinical Neuroimmunology, manuel.comabella@vhir.org
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.